Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Development (Cambridge, England)|October 14, 2008
Pbx1 functions in distinct regulatory networks to pattern the great arteries and cardiac outflow tractChing-Pin Chang, Kryn Stankunas, Ching Shang, et al.
The American Journal of Pathology|October 7, 2004
Pbx3 deficiency results in central hypoventilationJoon Whan Rhee, Akiko Arata, Licia Selleri, et al.
Plos One|September 17, 2013
MLL becomes functional through intra-molecular interaction not by proteolytic processingAkihiko Yokoyama, Francesca Ficara, Mark J Murphy, et al.
Cell Reports|September 22, 2021
Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemiaFabrizio Simeoni, Isabel Romero-Camarero, Francesco Camera, et al.
Cancer Cell|April 3, 2012
The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cellsWilliam J Harris, Xu Huang, James T Lynch, et al.
Blood Neoplasia|June 2, 2025
Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal responseNaveen Pemmaraju, Tim C P Somervaille, Francesca Palandri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid LeukemiaOlga Salamero, Pau Montesinos, Christophe Willekens, et al.
Oncogene|September 28, 2022
HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation blockAlba Maiques-Diaz, Luciano Nicosia, Naseer J Basma, et al.
Development (Cambridge, England)|June 10, 2005
A Pbx1-dependent genetic and transcriptional network regulates spleen ontogenyAndrea Brendolan, Elisabetta Ferretti, Valentina Salsi, et al.
Leukemia & Lymphoma|March 19, 2024
Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trialVikas Gupta, Stephen Oh, Timothy Devos, et al.
Pageof 16